UK SAG-CS publishes final opinion on Kojic Acid
Ingredients: Kojic Acid

The UK's Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) published its final opinion on Kojic Acid as used in cosmetic products.

The Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) is acknowledged as the UK’s counterpart of EU’s Scientific Committee on Consumer Safety (SCCS). GAC-CS assesses the chemical and biological risks of non-food and non-medicinal consumer products, including cosmetic products and their ingredients, and offers scientific opinions to the UK’s Office for Product Safety and Standards (OPSS).

The UK’s SAG-CS has recently published its final opinion on the use of Kojic Acid in cosmetic products.

BACKGROUND

Kojic Acid is a natural product derived from fungi and is largely used as a skin lightening/whitening or depigmenting agent in cosmetic products through action as a tyrosinase inhibitor. Such products are predominantly leave-on hand and face creams with concentrations of Kojic Acid in such products generally in the range of 1-4%. Kojic Acid may further function as an antioxidant, a bacteriostat (prevents the growth of bacteria), a metal chelating agent and an intermediate in chemical synthesis.

Kojic Acid has been reported to interfere with iodine uptake, resulting in altered thyroid function in rodents.

Kojic Acid is not currently regulated under the UK Cosmetic Products Regulation.

WHAT’S NEW?

SAG-CS Members agreed that Kojic Acid is safe for use at a maximum concentration of up to
1%
in face cream (including application to neck) and hand cream.

References:

Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) – Final Opinion on Kojic Acid in Cosmetic Products, 2023

other REGULATORY UPDATES

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »
Any REGULATORY QUESTION?

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »